Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jul 2026 for Whitehawk Therapeutics, Inc., €4.3M.
Filing timeline
BuySaleAnupam Dalal
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Anupam Dalal: trading record in brief
Anupam Dalal (board member) discloses dealings in Whitehawk Therapeutics, Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 31 March 2021 to 14 May 2026.
Purchases make up the whole of the open-market record (2 purchases, €34.0M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 share grants.
The latest filing, published on 30 July 2026, reports a share grant of €4.3M in Whitehawk Therapeutics, Inc. The last insider purchase was made public on 31 August 2021, 1,880 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anupam Dalal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
1,275,510 shares@ US$3.920.25% mcap100.0% of flowCommon StockSEC:0001602474-26-000004:0
1,561,000 shares@ US$2.404.7% of flowCommon StockSEC:0001415889-25-007096:0
320,000 shares@ US$12.505.5% of flowCommon StockSEC:0001209191-22-051390:0
1,529,402 shares@ US$13.07725.0% of flowCommon StockSEC:0000899243-21-034635:0
Canonical exit: 24 Nov 2021 (T+90)
1,529,402 shares@ US$13.07768.8% of flowCommon StockSEC:0000899243-21-034546:0
Canonical exit: 24 Nov 2021 (T+90)
7,400 shares@ US$1.52100.0% of flowCommon StockSEC:0000899243-21-027291:0
6 of 6 declarations
